These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3768260)

  • 21. Armadillo as a model for studying chemotherapy of leprosy: preliminary studies.
    Dhople AM
    Indian J Lepr; 1986; 58(1):19-28. PubMed ID: 3745995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cancer chemotherapy on dapsone N-acetylation in man.
    Philip PA; Harper PG; Rogers HJ
    Cancer Chemother Pharmacol; 1989; 23(6):395-6. PubMed ID: 2713961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
    Coleman MD; Tingle MD; Winn MJ; Park BK
    J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessment of dapsone as a marker of acetylator phenotypes.
    Wiggan EB; Dennis S; Reele SB; Luke DR
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):262-8. PubMed ID: 1889912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of chloroquine, dapsone and pyrimethamine in human milk.
    Edstein MD; Veenendaal JR; Newman K; Hyslop R
    Br J Clin Pharmacol; 1986 Dec; 22(6):733-5. PubMed ID: 3567020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylator phenotyping: the effect of ethanol on the dapsone test.
    Hutchings A; Monie RD; Spragg B; Routledge PA
    Br J Clin Pharmacol; 1984 Jul; 18(1):98-100. PubMed ID: 6743494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone.
    Pochopin NL; Charman WN; Stella VJ
    Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute dapsone intoxication: a case with prolonged symptoms.
    Elonen E; Neuvonen PJ; Halmekoski J; Mattila MJ
    Clin Toxicol; 1979; 14(1):79-85. PubMed ID: 436385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine.
    Abuirjeie MA; Irshaid YM; al-Hadidi HF; Rawashdeh NM
    J Clin Pharm Ther; 1991 Aug; 16(4):247-55. PubMed ID: 1939403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of effects of altered gastric pH on absorption of dapsone in healthy volunteers.
    Breen GA; Brocavich JM; Etzel JV; Shah V; Schaefer P; Forlenza S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2227-9. PubMed ID: 7811056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of dapsone in protein deficiency--an experimental study in mice.
    Venkatesan K; Bharadwaj VP; Sritharan V; Sreevatsa ; Girdhar BK
    Lepr India; 1982 Jan; 54(1):95-9. PubMed ID: 7098446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained release properties of an intra-adiposely administered dapsone depot injection.
    Pieters FA; Zuidema J; Merkus FW
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):383-8. PubMed ID: 3746042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
    Hanson A; Melander A; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid method for determination of acetylation phenotype using dapsone.
    Philip PA; Roberts MS; Rogers HJ
    Br J Clin Pharmacol; 1984 Apr; 17(4):465-9. PubMed ID: 6721993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.
    Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
    Clin Pharmacol Ther; 1995 Nov; 58(5):556-66. PubMed ID: 7586950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex differences in the absorption of dapsone after intramuscular injection.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):359-65. PubMed ID: 6685698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.